Study on plasma alkaline phosphatase concentration in ischemic stroke patients

  • Nguyen Van Tuyen 108 Military Central Hospital
  • Nguyen Cam Thach 108 Military Central Hospital
  • Dinh Thi Thao 108 Military Central Hospital

Main Article Content

Keywords

Ischemic stroke, ALP concentration, 108 Military Central Hospital

Abstract

Objective: To evaluate of changes in plasma alkaline phosphatase (ALP) of patients with ischemic stroke (IS) at 108 Military Central Hospital. Initial investigation of the prognostic role of plasma ALP for developing IS events. Subject and method: 70 healthy individuals and 120 IS patients that were treated at Stroke Center - 108 Military Central Hospital from 6/2021 to 12/2021. The participants were clinically examined, having CT scan or MRI of brain, taking ALP and biological indicators tests upon hospitalization. Result: The plasma ALP levels of patients with IS (258.94 ± 34.56U/L) were significant higher than those of control group (197.31 ± 16.25U/L), p<0.01. The cutoff threshold of ALP levels was 238U/l that could distinguish IS patients from control group with the area under ROC curve was 0.798; 95% confident interval: 0.651 - 0.962, p<0.01. Univariate analysis shown that individuals with elevated ALP levels had 1.72 fold increased risk of cerebral infarction compared with those with normal ALP concentrations (95% CI: 1.43 - 2.11, p<0.05). There was no association between plasma ALP levels and IS in multivariate analysis (OR = 1.084, 95% CI: 1.074 - 1.094, p>0.05). Conclusion: The cutoff threshold of ALP levels was 238U/l that could independently discriminate IS group from control group. ALP level was not an independent prognostic marker of IS, p>0.05.

Article Details

References

1. ShilpaSree AS, Sahukar S, Murthy J, Kumar K (2013) A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke. Journal of clinical and diagnostic research 7(7): 1303-1306.
2. Liu Y, Liang X, Xu X et al (2019) Increased serum alkaline phosphatase in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 28(1): 21-25.
3. Kim J, Song TJ, Song D et al (2013) Serum alkaline phosphatase and phosphate in cerebral atherosclerosis and functional outcomes after cerebral infarction. Stroke 44: 3547.
4. Ryu WS, Lee SH, Kim CK et al (2010) Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke. Neurology 75: 1995-2002.
5. Brichacek AL, Brown CM (2018) Alkaline phosphatase: a potential biomarker for stroke and implications for treatment. Metabolic Brain Disease. doi:10.1007/s11011-018-0322-3.
6. Muscari A, Collini A, Fabbri E et al (2014) Changes of liver enzymes and bilirubin during ischemic stroke: Mechanisms and possible significance. BMC Neurology 14(1).
7. Uehara T, Ohara T, Minematsu K et al (2018) Predictors of stroke events in patients with transient ischemic attack attributable to intracranial stenotic lesions. Internal Medicine 57(3): 295-300.
8. Tonelli M, Curhan G, Pfeffer M et al (2009) Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120: 1784.
9. Christine A, Turan TN and Chimowitz MI (2013) Atherosclerotic intracranial arterial stenosis: Risk factors, diagnosis, and treatment. Lancet neurology 12(11): 1106-1114.
10. Boehme AK, Esenwa C, Elkind MSV (2017) Stroke risk factors, genetics, and prevention. Circulation Research 120(3): 472-495.
11. Wolf PA, Abbott RD, Kannel WB (1991). Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 22: 983-988.